Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001144204-14-050899
Filing Date
2014-08-18
Accepted
2014-08-15 19:50:38
Documents
12

Document Format Files

Seq Description Document Type Size
1 424B4 v387053_424b4.htm 424B4 866338
2 GRAPHIC logo_cellectar-cmyk.jpg GRAPHIC 6964
3 GRAPHIC line.gif GRAPHIC 43
4 GRAPHIC spacer.gif GRAPHIC 43
5 GRAPHIC v383864_img-platform.jpg GRAPHIC 50744
6 GRAPHIC v383864_img-imaging1.jpg GRAPHIC 19527
7 GRAPHIC v383864_img-imaging2.jpg GRAPHIC 28864
8 GRAPHIC v383864_img-imaging3.jpg GRAPHIC 15974
9 GRAPHIC v385786_chrt-pipeline.jpg GRAPHIC 40247
10 GRAPHIC v383864_img-lipid.jpg GRAPHIC 17387
11 GRAPHIC v383864_img-imaging4.jpg GRAPHIC 14395
12 GRAPHIC v383864_img-imaging5.jpg GRAPHIC 35422
  Complete submission text file 0001144204-14-050899.txt   1185573
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-196091 | Film No.: 141047737
SIC: 2834 Pharmaceutical Preparations